Esperion Therapeutics Stock (NASDAQ:ESPR)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$2.03

52W Range

$0.87 - $3.40

50D Avg

$1.87

200D Avg

$2.21

Market Cap

$392.45M

Avg Vol (3M)

$3.46M

Beta

1.00

Div Yield

-

ESPR Company Profile


Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

240

IPO Date

Jun 26, 2013

Website

ESPR Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Product$78.33M$55.86M-
Collaboration Revenue$38.00M$19.61M$38.40M
Royalty Revenue From DSE--$9.90M

Fiscal year ends in Dec 23 | Currency in USD

ESPR Financial Summary


Dec 23Dec 22Dec 21
Revenue$116.33M$75.47M$78.45M
Operating Income$-155.56M$-179.50M$-226.73M
Net Income$-209.25M$-287.82M$-318.82M
EBITDA$-155.56M$-176.85M$-222.75M
Basic EPS-$-4.33$-11.03
Diluted EPS-$-4.33$-11.03

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Aug 12, 24 | 9:50 PM
Q1 24May 07, 24 | 12:00 AM
Q4 23Feb 27, 24 | 11:18 AM

Peer Comparison


TickerCompany
ELANElanco Animal Health Incorporated
ITCIIntra-Cellular Therapies, Inc.
ANIPANI Pharmaceuticals, Inc.
LFCRLifecore Biomedical, Inc.
PAHCPhibro Animal Health Corporation
NBIXNeurocrine Biosciences, Inc.
IRWDIronwood Pharmaceuticals, Inc.
DCPHDeciphera Pharmaceuticals, Inc.
PBHPrestige Consumer Healthcare Inc.
RMTIRockwell Medical, Inc.
AGRXAgile Therapeutics, Inc.
ALKSAlkermes plc
KMDAKamada Ltd.
PCRXPacira BioSciences, Inc.
COLLCollegium Pharmaceutical, Inc.
CTLTCatalent, Inc.
AVDLAvadel Pharmaceuticals plc
SIGASIGA Technologies, Inc.
EGRXEagle Pharmaceuticals, Inc.